These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37496455)

  • 1. Benchmark dose modeling for epidemiological dose-response assessment using prospective cohort studies.
    De Pretis F; Zhou Y; Xun P; Shao K
    Risk Anal; 2024 Apr; 44(4):743-756. PubMed ID: 37496455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
    Shao K; Zhou Z; Xun P; Cohen SM
    Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Web-Based System for Bayesian Benchmark Dose Estimation.
    Shao K; Shapiro AJ
    Environ Health Perspect; 2018 Jan; 126(1):017002. PubMed ID: 29329100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.
    Shao K; Gift JS
    Risk Anal; 2014 Jan; 34(1):101-20. PubMed ID: 23758102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computational system for Bayesian benchmark dose estimation of genomic data in BBMD.
    Ji C; Weissmann A; Shao K
    Environ Int; 2022 Mar; 161():107135. PubMed ID: 35151117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of transcriptomic datasets using benchmark dose modeling shows value in supporting radiation risk assessment.
    Chauhan V; Adam N; Kuo B; Williams A; Yauk CL; Wilkins R; Stainforth R
    Int J Radiat Biol; 2021; 97(1):31-49. PubMed ID: 32687419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for application of benchmark dose modeling in radiation research: workshop highlights.
    Chauhan V; Yu J; Vuong N; Haber LT; Williams A; Auerbach SS; Beaton D; Wang Y; Stainforth R; Wilkins RC; Azzam EI; Richardson RB; Khan MGM; Jadhav A; Burtt JJ; Leblanc J; Randhawa K; Tollefsen KE; Yauk CL
    Int J Radiat Biol; 2023; 99(9):1320-1331. PubMed ID: 36881459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benchmark dose modeling of transcriptional data: a systematic approach to identify best practices for study designs used in radiation research.
    Stainforth R; Vuong N; Adam N; Kuo B; Wilkins RC; Yauk C; Beheshti A; Chauhan V
    Int J Radiat Biol; 2022; 98(12):1832-1844. PubMed ID: 35939275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of the benchmark dose approach to epidemiological endpoints with clinical standards].
    Murata K; Karita K; Horiguchi H; Iwata T; Hirose A
    Sangyo Eiseigaku Zasshi; 2011; 53(3):67-77. PubMed ID: 21467775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benchmark Dose Analysis via Nonparametric Regression Modeling.
    Piegorsch WW; Xiong H; Bhattacharya RN; Lin L
    Risk Anal; 2014 Jan; 34(1):135-51. PubMed ID: 23683057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current state of knowledge on the use of the benchmark dose concept in risk assessment.
    Sand S; Victorin K; Filipsson AF
    J Appl Toxicol; 2008 May; 28(4):405-21. PubMed ID: 17879232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Prior Toxicological Data to Support Dose-Response Assessment─Identifying Plausible Prior Distributions for Dichotomous Dose-Response Models.
    Shao K; Ji C; Chiu WA
    Environ Sci Technol; 2022 Nov; 56(22):16506-16516. PubMed ID: 36279400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of subchronic toxicity data using the benchmark dose approach.
    Gephart LA; Salminen WF; Nicolich MJ; Pelekis M
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):37-59. PubMed ID: 11259178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cancer risk assessment for nickel compounds: issues associated with dose-response modeling of inhalation and oral exposures.
    Haber LT; Allen BC; Kimmel CA
    Toxicol Sci; 1998 Jun; 43(2):213-29. PubMed ID: 9710963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.